Inhibikase Therapeutics, Inc. short interest in 2025
In 2025, Inhibikase Therapeutics, Inc.'s disclosed short interest ran from 1.33% of shares outstanding on 15 Jan 2025 to 8.98% on 31 Dec 2025, a change of +7.65 percentage points. The year's high was 8.98% on 31 Dec 2025 and its low 1.33% on 15 Jan 2025, averaging 3.54% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 37.96 days on 29 Aug 2025. Full history: Inhibikase Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 1.33% (15 Jan 2025)
- End of year
- 8.98% (31 Dec 2025)
- Change
- +7.65 pp
- High
- 8.98% (31 Dec 2025)
- Low
- 1.33% (15 Jan 2025)
- Average
- 3.54%
- Highest days to cover
- 37.96 (29 Aug 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 1.33% | 5.98 | |
| 31 Jan 2025 | 1.59% | 4.74 | |
| 14 Feb 2025 | 1.88% | 7.56 | |
| 28 Feb 2025 | 2.05% | 6.22 | |
| 14 Mar 2025 | 1.94% | 11.06 | |
| 31 Mar 2025 | 1.77% | 10.05 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 1.91% | 9.05 | |
| 30 Apr 2025 | 1.96% | 12.66 | |
| 15 May 2025 | 1.86% | 12.57 | 10-Q filed, results (8-K) |
| 30 May 2025 | 2.09% | 12.37 | |
| 13 Jun 2025 | 2.13% | 16.34 | |
| 30 Jun 2025 | 4.39% | 3.57 | |
| 15 Jul 2025 | 4.13% | 22.26 | |
| 31 Jul 2025 | 4.08% | 24.48 | |
| 15 Aug 2025 | 4.42% | 29.80 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 4.46% | 37.96 | |
| 15 Sep 2025 | 4.27% | 31.58 | |
| 30 Sep 2025 | 4.67% | 18.97 | |
| 15 Oct 2025 | 4.29% | 36.12 | |
| 31 Oct 2025 | 4.06% | 31.61 | |
| 14 Nov 2025 | 4.10% | 23.59 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 5.51% | 7.68 | |
| 15 Dec 2025 | 7.11% | 13.78 | |
| 31 Dec 2025 | 8.98% | 8.50 |
See also: Inhibikase Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.